Friday, December 5, 2025

FDA awards FDASIA advanced generic drug capabilities Support task to Booz Allen Hamilton

Beating out two other bidders Booz Allen Hamilton was recently awarded a 2-year task with the Food and Drug Administration for FDASIA support, to provide advanced generic drug and drug quality capabilities. The task was awarded using the FDA Safety and Innovation Act (FDASIA) Support Services BPA.

Awardee Name: BOOZ ALLEN HAMILTON INC.
Contract Duration: 24 months
Total Contract Value: $6,172,061.56
Action Obligation: $3,172,700.74
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 3
RFP ID: FDA-20-RFQ-1222104
Award ID: 75F40120F19005

Booz Allen Hamilton was recently named to the updated list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Innovation in Action: Advancing Government Health with Philips

FORUM is proud to partner with Philips for a series of articles on their groundbreaking innovations in health technology that serve public- and private sector citizens and service members. Please take a look to learn more about how Philips is advancing modern and efficient health care, while improving lives for generations to come.

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required